PF08634404
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF08634404, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer [Phase 2]